Vamifeport hydrochloride

N/A

Report date: 2026/03/28 20:00:32
NME

Base Information

Drug NameVamifeport hydrochloride
Drug Alias NameVIT2763VamifeportVIT-2763
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFerroportin-1 inhibitors
TargetsFerroportin-1
Therapy Area/IndicationsHemochromatosisbeta-ThalassemiaThalassemia +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[23
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVifor
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHemochromatosisbeta-ThalassemiaThalassemia +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A